XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.23.2

Commitments and Contingencies (Tables) | 9 Months Ended
--- | ---
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract] |
Schedule of share purchase warrants outstanding |
| Schedule of share purchase warrants outstanding |  |  |  |  |  |  |
Number |  | Exercise Price |  | Expiry Date
| 150,000 |  |  | $ | 3.17 |  |  | May 6, 2024
| 10,000 |  |  | $ | 12.00 |  |  | April 21, 2026
| 160,000 |  |  |  |  |  |  |
Schedule of outstanding stock purchase options |
Schedule of outstanding stock purchase options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Weighted Average |  |
|  |  |  | Weighted Average |  | Grant Date Fair |  | Aggregate intrinsic
|  |  |  | Exercise Price |  | Value |  | Value
|  | Number of Options |  | ($) |  | ($) |  | ($)
Outstanding, September 30, 2021 |  |  |  | 11,330,903 |  |  |  | 5.74 |  |  |  | — |  |  |  | 140,132,451 |
Granted |  |  |  | 2,358,000 |  |  |  | 10.13 |  |  |  | 7.07 |  |  |  | — |
Forfeited |  |  |  | (118,750 | ) |  |  | 6.56 |  |  |  | 5.23 |  |  |  | — |
Exercised |  |  |  | (400,537 | ) |  |  | 2.52 |  |  |  | 1.88 |  |  |  | 4,201,015 |
Outstanding, September 30, 2022 |  |  |  | 13,169,616 |  |  |  | 6.61 |  |  |  |  |  |  |  | 62,267,309 |
Granted |  |  |  | 1,914,000 |  |  |  | 9.33 |  |  |  | 6.62 |  |  |  | — |
Exercised |  |  |  | (234,753 | ) |  |  | 3.87 |  |  |  | 2.91 |  |  |  | 1,297,062 |
Forfeited |  |  |  | (150,000 | ) |  |  | 12.69 |  |  |  | 5.64 |  |  |  | — |
Outstanding, June 30, 2023 |  |  |  | 14,698,863 |  |  |  | 6.95 |  |  |  |  |  |  |  | 39,065,774 |
Exercisable, June 30, 2023 |  |  |  | 10,027,446 |  |  |  | 4.91 |  |  |  |  |  |  |  | 38,730,916 |
Schedule Of Share-based Payment Arrangement, Option, Activity |
| Schedule Of Share-based Payment Arrangement, Option, Activity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Weighted average |  |  |  |  |  |
|  |  |  | Number of |  | remaining |  | Weighted |  | Number of |  | Weighted
Range of exercises prices |  | outstanding |  | contractual life |  | average |  | vested |  | average
From |  | To |  | options |  | (in years) |  | exercise price |  | options |  | exercise price
$ | 0.92 |  |  | $ | 3.00 |  |  |  | 3,800,309 |  |  |  | 4.34 |  |  | $ | 2.29 |  |  |  | 3,800,309 |  |  | $ | 2.29 |
$ | 3.01 |  |  | $ | 5.00 |  |  |  | 2,022,500 |  |  |  | 4.57 |  |  | $ | 3.28 |  |  |  | 2,022,500 |  |  | $ | 3.28 |
$ | 5.01 |  |  | $ | 9.00 |  |  |  | 5,250,054 |  |  |  | 6.46 |  |  | $ | 6.91 |  |  |  | 3,287,887 |  |  | $ | 6.09 |
$ | 9.01 |  |  | $ | 13.00 |  |  |  | 2,054,000 |  |  |  | 8.64 |  |  | $ | 10.62 |  |  |  | 432,167 |  |  | $ | 11.47 |
$ | 13.01 |  |  | $ | 25.00 |  |  |  | 1,572,000 |  |  |  | 7.74 |  |  | $ | 18.29 |  |  |  | 484,583 |  |  | $ | 18.50 |
|  |  |  |  |  |  |  |  | 14,698,863 |  |  |  | 6.09 |  |  | $ | 6.95 |  |  |  | 10,027,446 |  |  | $ | 4.91 |
Schedule of general and administrative expenses and research and development expenses |
Schedule of general and administrative expenses and research and development expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Three months ended June 30, |  | Nine months ended June 30,
|  | 2023 |  | 2022 |  | 2023 |  | 2022
General and administrative |  | $ | 1,451,471 |  |  | $ | 1,490,267 |  |  | $ | 4,450,841 |  |  | $ | 4,739,021 |
Research and development |  |  | 2,415,310 |  |  |  | 2,498,347 |  |  |  | 8,732,512 |  |  |  | 7,597,823 |
Total stock-based compensation |  | $ | 3,866,781 |  |  | $ | 3,988,614 |  |  | $ | 13,183,353 |  |  | $ | 12,336,844 |
Schedule of weighted average assumptions for fair value of each option award |
Schedule of weighted average assumptions for fair value of each option award |  |  |  |  |  |  |  |
|  | 2023 |  | 2022
Risk-free interest rate |  |  | 3.69 | % |  |  | 3.10 | %
Expected life of options (years) |  |  | 5.63 |  |  |  | 5.51 |
Annualized volatility |  |  | 85.16 | % |  |  | 84.12 | %
Dividend rate |  |  | 0.00 | % |  |  | 0.00 | %

X
- References No definition available. + Details
Name: | avxl_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock
Namespace Prefix: | avxl_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References No definition available. + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration